Prevention and treatment of cancer-related infections.
Prevention and treatment of cancer-related infections.
复制标题
DOI:
10.6004/jnccn.2008.0013
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
L. Baden;W. Bensinger;M. Angarone;C. Casper;E. Dubberke;A. Freifeld;R. Garzon;J. Greene;J. Greer;J. Ito;J. Karp;D. Kaul;E. King;Emily R. Mackler;K. Marr;J. Montoya;Ashley Morris-Engemann;P. Pappas;K. Rolston;B. Segal;S. Seo;S. Swaminathan;M. Naganuma;Dorothy Shead
中科院分区:
文献类型:
--
作者:
L. Baden;W. Bensinger;M. Angarone;C. Casper;E. Dubberke;A. Freifeld;R. Garzon;J. Greene;J. Greer;J. Ito;J. Karp;D. Kaul;E. King;Emily R. Mackler;K. Marr;J. Montoya;Ashley Morris-Engemann;P. Pappas;K. Rolston;B. Segal;S. Seo;S. Swaminathan;M. Naganuma;Dorothy Shead
Patients with cancer are at increased risk for developing infectious complications during the course of their disease and treatment. The following sections of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections provide an overview of the risk factors for infectious complications, recommendations for infectious risk categorization, and strategies for prevention of infections in high-risk patient populations with cancer. Individualized risk evaluation for infections and incorporation of preventative measures are essential components of the overall spectrum of cancer care, and may contribute to optimizing treatment outcomes for patients.